- In May 2023, At EuroMedLab Rome 2023, Sansure Biotech presented its iPonatic III, a portable molecular workstation designed for point-of-care testing. The device's compact design and wireless connectivity cater to the increasing demand for decentralized diagnostic solutions, enhancing the accessibility and efficiency of molecular diagnostics
- In April 2023, Molbio Diagnostics introduced Truenat H3N2/H1N1, the first point-of-care real-time PCR test approved by India's CDSCO for the differential diagnosis of H3N2 and H1N1 influenza viruses. Delivering results within an hour, this innovation addresses the need for rapid, on-site testing solutions, supporting market growth in infectious disease diagnostics.
- In April 2023, Alercell launched the LENA Molecular Dx Leukemia Platform, comprising 12 next-generation sequencing-based molecular diagnostic tests for early leukemia detection, treatment guidance, and minimal residual disease monitoring. This platform exemplifies the expanding application of NGS in oncology, contributing to the growth of molecular diagnostics in cancer care
- In February 2023, Thermo Fisher Scientific introduced the QuantStudio Absolute Q AutoRun Digital PCR Suite, an automated, high-throughput solution for precise nucleic acid quantification. Designed for extended hands-free operation, this system enhances the precision and sensitivity of molecular diagnostics, supporting advancements in research and clinical applications
- In January 2023, QIAGEN and Helix announced an exclusive partnership to develop next-generation sequencing-based companion diagnostics for hereditary diseases. Leveraging Helix's FDA-authorized laboratory platform and QIAGEN's global regulatory expertise, this collaboration emphasizes the integral role of NGS in early disease detection and personalized medicine, fostering market expansion
